Efinaconazole is a topical antifungal medication used to treat onychomycosis, a fungal infection of the nails [1]. It is a triazole antifungal agent [2].
How does efinaconazole work?
Efinaconazole functions by inhibiting the enzyme 14α-demethylase, which is crucial for the synthesis of ergosterol [2]. Ergosterol is a vital component of fungal cell membranes. By disrupting ergosterol production, efinaconazole compromises the integrity and function of the fungal cell membrane, leading to fungal cell death [2].
What is efinaconazole used for?
Efinaconazole is indicated for the topical treatment of onychomycosis of the toenails in patients 17 years of age and older, caused by Trichophyton rubrum and Trichophyton mentagrophytes [1]. It is applied directly to the affected nails [1].
How is efinaconazole supplied and dosed?
Efinaconazole is available as a topical solution, typically in a 10% concentration [1][2]. It is applied once daily to the affected toenails until the infection has cleared. Treatment duration can vary but often extends for 48 weeks [1].
What are the potential side effects of efinaconazole?
The most common side effects reported with efinaconazole use include ingrown toenails, swelling of the toes, and blisters on the skin around the application site [1]. Other less common side effects can occur [1].
Are there any contraindications for efinaconazole?
Efinaconazole is contraindicated in individuals with a known hypersensitivity to efinaconazole or any of its components [1].
What is the patent status for efinaconazole?
The patent landscape for efinaconazole can be complex and is subject to change. Information on specific patents and their expiry dates can be found through resources like DrugPatentWatch.com [3]. DrugPatentWatch.com tracks patent filings, grants, and expiry dates for pharmaceutical products, which can include detailed information on branded and generic drugs like efinaconazole [3].
How does efinaconazole compare to other nail fungus treatments?
Other topical treatments for onychomycosis include ciclopirox and tavaborole [4]. Oral antifungal medications like terbinafine and itraconazole are also used, though they carry a higher risk of systemic side effects and drug interactions [4]. Efinaconazole's specific efficacy and safety profile differentiate it from these other options [1][4].